These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 31277977

  • 1. A case of clozapine induced agranulocytosis 25 years after starting treatment: Effective use of lithium for augmentation in rechallenge.
    Martina AC, Ee JS, Lamberti JS.
    Schizophr Res; 2019 Aug; 210():308-309. PubMed ID: 31277977
    [No Abstract] [Full Text] [Related]

  • 2. Lithium and clozapine-induced neutropenia/agranulocytosis.
    Blier P, Slater S, Measham T, Koch M, Wiviott G.
    Int Clin Psychopharmacol; 1998 May; 13(3):137-40. PubMed ID: 9690982
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G, Eskelinen S, Sailas E.
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Optimizing outcomes in clozapine rechallenge following neutropenia: a cohort analysis.
    Meyer N, Gee S, Whiskey E, Taylor D, Mijovic A, Gaughran F, Shergill S, MacCabe JH.
    J Clin Psychiatry; 2015 Nov; 76(11):e1410-6. PubMed ID: 26646037
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Severe clozapine-induced agranulocytosis: successful treatment with G-CSF and rechallenge of clozapine plus D2 potentiation therapy (amisulpride).
    Ruiz-Doblado S, Plasencia-García de Diego B, Perea-Pérez R, Jiménez-Gonzalo F.
    Actas Esp Psiquiatr; 2020 Mar; 48(2):89-91. PubMed ID: 32463914
    [No Abstract] [Full Text] [Related]

  • 14. Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be Risky.
    Boazak M, Goldsmith DR, Cotes RO.
    Prim Care Companion CNS Disord; 2018 Nov 29; 20(6):. PubMed ID: 30549484
    [No Abstract] [Full Text] [Related]

  • 15. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S, Rosenius S, Spigset O.
    Int Clin Psychopharmacol; 2003 May 29; 18(3):173-4. PubMed ID: 12702898
    [Abstract] [Full Text] [Related]

  • 16. Clozapine-induced agranulocytosis: a case report. Immunopathophysiological considerations.
    van de Loosdrecht AA, Faber HJ, Hordijk P, Uges DR, Smit A.
    Neth J Med; 1998 Jan 29; 52(1):26-9. PubMed ID: 9573739
    [Abstract] [Full Text] [Related]

  • 17. Clozapine: the commitment to patient safety.
    Alphs LD, Anand R.
    J Clin Psychiatry; 1999 Jan 29; 60 Suppl 12():39-42. PubMed ID: 10372610
    [Abstract] [Full Text] [Related]

  • 18. Clozapine-induced agranulocytosis after 11 years of treatment.
    Sedky K, Shaughnessy R, Hughes T, Lippmann S.
    Am J Psychiatry; 2005 Apr 29; 162(4):814. PubMed ID: 15800170
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.